Only a few studies have quantified CXCL12 or CXCR4 expression directly in human lung tissues or characterized temporal changes during disease progression, and interventional clinical data targeting this axis in sepsis or ALI are effectively nonexistent. The gene discussed is CXCL12; the disease is Sepsis.